Live Breaking News & Updates on Catalyst Pharmaceuticals Company Profile

Stay updated with breaking news from Catalyst pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hussman Strategic Advisors Inc. Purchases 64,500 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Hussman Strategic Advisors Inc. Purchases 64,500 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Davids Tierney , Alicia Grande , Catalyst Pharmaceuticals Inc , Jump Financial , Catalyst Pharmaceuticals Company Profile , Hussman Strategic Advisors Inc , Illinois Municipal Retirement Fund , Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Stock Down , York State Common Retirement Fund , News Ratings For Catalyst Pharmaceuticals Daily , Quarter For Catalyst Pharmaceuticals , Securities Exchange Commission , Victory Capital Management Inc , Hussman Strategic Advisors , Free Report , Strategic Advisors , Municipal Retirement Fund , Victory Capital Management , Capital Management , Director David , Exchange Commission , Pharmaceuticals Stock Down , Get Free Report ,

Jackson Creek Investment Advisors LLC Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Jackson Creek Investment Advisors LLC purchased a new stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 68,210 shares of the biopharmaceutical company’s stock, valued at approximately $797,000. A number […] ....

United States , Steve Miller , Alicia Grande , Catalyst Pharmaceuticals Stock Down , Denali Advisors , Exchange Commission , Quarter For Catalyst Pharmaceuticals , Securities Exchange Commission , Barclays Plc , Jackson Creek Investment Advisors , Catalyst Pharmaceuticals Company Profile , News Ratings For Catalyst Pharmaceuticals Daily , Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Inc , Free Report , Strs Ohio , Pharmaceuticals Stock Down , Get Free Report , Visit Holdingschannel , Catalyst Pharmaceuticals Daily , Nasdaq Cprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Catalyst Pharmaceuticals (NASDAQ:CPRX) Shares Gap Down to $17.11

Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $17.11, but opened at $14.58. Catalyst Pharmaceuticals shares last traded at $14.81, with a volume of 1,673,229 shares. Analyst Ratings Changes CPRX has been the topic of a number of research […] ....

United States , Alicia Grande , Davids Tierney , Catalyst Pharmaceuticals Inc , Securities Exchange Commission , News Ratings For Catalyst Pharmaceuticals Daily , Catalyst Pharmaceuticals Stock Down , Catalyst Pharmaceuticals Company Profile , Denali Advisors , Catalyst Pharmaceuticals , Insider Activity At Catalyst Pharmaceuticals , Barclays Plc , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Director David , Strs Ohio , Catalyst Pharmaceuticals Daily , Nasdaq Cprx ,

Insider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Director Sells 50,000 Shares of Stock

Insider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Director Sells 50,000 Shares of Stock
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United States , Davids Tierney , Advisory Services Network , News Ratings For Catalyst Pharmaceuticals Daily , Catalyst Pharmaceuticals Company Profile , Quarter For Catalyst Pharmaceuticals , Covestor Ltd , Visionpoint Advisory Group , Catalyst Pharmaceuticals Price Performance , Institutional Investors Weigh In On Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Inc , Cantor Fitzgerald , Catalyst Pharmaceuticals , Get Free Report , Director David , Services Network , Point Advisory Group , Catalyst Pharmaceuticals Daily ,

Insider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells 40,000 Shares of Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Steve Miller sold 40,000 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $14.24, for a total transaction of $569,600.00. Following the transaction, the insider now directly owns 647,457 shares of the company’s stock, […] ....

United States , Steve Miller , Catalyst Pharmaceuticals Company Profile , Blackrock Inc , Catalyst Pharmaceuticals Stock , Cantor Fitzgerald , Institutional Trading Of Catalyst Pharmaceuticals , Vanguard Group Inc , Millennium Management , Catalyst Pharmaceuticals , Jupiter Asset Management Ltd , Securities Exchange Commission , Catalyst Pharmaceuticals Inc , News Ratings For Catalyst Pharmaceuticals Daily , Get Free Report , Exchange Commission , Street Corp , Asset Management , Vanguard Group , Catalyst Pharmaceuticals Daily , Nasdaq Cprx , Insider Trading , Nsider Trades ,